Effect of Combined Use of Calcium and Vitamin B6 on premenstrual Syndrome
Phase 2
- Conditions
- premenstrual syndrome.premenstrual tension syndrome
- Registration Number
- IRCT2014070313405N3
- Lead Sponsor
- Vice Chancellor of Research of Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 76
Inclusion Criteria
regular menstrual periods with 21-35 days cycles and 3-10 days bleeding period; no known psychological diseases; no physical diseases such as diabetes, seizure disorders, hypothyroidism and so on; no Surgery, death of close relatives; divorce or other adverse events in the last three months; no Antidepressants, hormonal contraceptives, medroxyprogesterone acetate, and vitamins taken in the past three months; Exclusion criteria: pregnancy; incidents like the death of close relatives; divorce; and other adverse events.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of Premenstrual Syndrome. Timepoint: Eight weeks before treatment, Eight weeks after treatment. Method of measurement: Diagnostic and Statistical Manual of Mental Disorders, 4th. Edition.
- Secondary Outcome Measures
Name Time Method